Similar articles for PMID: 31308111

Year	Number of Results
2005	1
2006	2
2007	4
2008	5
2009	1
2010	2
2011	1
2012	4
2013	2
2014	2
2015	6
2016	9
2017	6
2018	10
2019	21
2020	20
2021	13
2024	0

1

Venous thromboembolism and palliative care.

Noble S. Noble S. Clin Med (Lond). 2019 Jul;19(4):315-318. doi: 10.7861/clinmedicine.19-4-315. Clin Med (Lond). 2019. PMID: 31308111 Free PMC article.

2

Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.

Tran QN. Tran QN. Am J Hosp Palliat Care. 2010 Sep;27(6):416-9. doi: 10.1177/1049909110361244. Epub 2010 Mar 2. Am J Hosp Palliat Care. 2010. PMID: 20197558 Review.

3

Evaluation of direct oral anticoagulants for the treatment of cancer-associated thrombosis: an update.

Franco-Moreno A, Cabezón-Gutiérrez L, Palka-Kotlowsa M, Villamayor-Delgado M, García-Navarro M. Franco-Moreno A, et al. J Thromb Thrombolysis. 2019 Apr;47(3):409-419. doi: 10.1007/s11239-018-1783-2. J Thromb Thrombolysis. 2019. PMID: 30467760 Review.

4

Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis.

Li A, Garcia DA, Lyman GH, Carrier M. Li A, et al. Thromb Res. 2019 Jan;173:158-163. doi: 10.1016/j.thromres.2018.02.144. Epub 2018 Mar 2. Thromb Res. 2019. PMID: 29506866 Free PMC article.

5

Meta-Analysis Comparing Direct Oral Anticoagulants to Low Molecular Weight Heparin for Treatment of Venous Thromboembolism in Patients With Cancer.

Bhatia K, Uberoi G, Bajaj NS, Jain V, Arora S, Tafur A, Bangalore S, Olin JW, Piazza G, Goldhaber SZ, Vaduganathan M, Qamar A. Bhatia K, et al. Am J Cardiol. 2020 Oct 15;133:175-178. doi: 10.1016/j.amjcard.2020.07.027. Epub 2020 Jul 25. Am J Cardiol. 2020. PMID: 32807386 No abstract available.

6

Network meta-analysis of anticoagulation strategies for venous thromboembolism in patients with cancer.

Ueyama H, Miyashita H, Takagi H, Cruz C, Burger A, Briasoulis A, Kuno T. Ueyama H, et al. J Thromb Thrombolysis. 2021 Jan;51(1):102-111. doi: 10.1007/s11239-020-02151-2. J Thromb Thrombolysis. 2021. PMID: 32458316

7

Treatment of Venous Thromboembolism in Cancer. Historical Perspective and Evolving Role of the Direct Oral Anticoagulants.

Carrier M, Soff G, Le Gal G. Carrier M, et al. Cancer Treat Res. 2019;179:103-115. doi: 10.1007/978-3-030-20315-3_7. Cancer Treat Res. 2019. PMID: 31317483

8

Factors Influencing the Choice between DOACs and LMWHs: A Survey of German Physicians on the Treatment of Cancer-Associated Venous Thromboembolism.

Matzdorff A, Langer F. Matzdorff A, et al. Hamostaseologie. 2020 Dec;40(5):655-661. doi: 10.1055/a-1129-2573. Epub 2020 Apr 30. Hamostaseologie. 2020. PMID: 32356293

9

Management of venous thromboembolism in the palliative care setting.

Noble S. Noble S. Int J Palliat Nurs. 2007 Dec;13(12):574-9. doi: 10.12968/ijpn.2007.13.12.27884. Int J Palliat Nurs. 2007. PMID: 18399382 Review.

10

Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.

Raskob GE, van Es N, Segers A, Angchaisuksiri P, Oh D, Boda Z, Lyons RM, Meijer K, Gudz I, Weitz JI, Zhang G, Lanz H, Mercuri MF, Büller HR; Hokusai-VTE investigators. Raskob GE, et al. Lancet Haematol. 2016 Aug;3(8):e379-87. doi: 10.1016/S2352-3026(16)30057-6. Epub 2016 Jul 1. Lancet Haematol. 2016. PMID: 27476789 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year